| Value | ₹16.89 Cr |
|---|
BSE filing, BSE: 543378. Summary written from the filing by ALFA Finder's alert engine.
CWD Ltd: key numbers
- Share price
- ₹267.85
- Market cap
- ₹659.8 Cr
- Revenue (annual)
- ₹141.8 Cr
- Net profit (annual)
- ₹10.67 Cr
- P/E (TTM)
- 61.8×Sector 42.1×
- Promoter holding
- 54.10%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from CWD Ltd
All →CWD Management Change
CWD Limited appointed CS Muskan Kachhawaha as Company Secretary and Compliance Officer effective 24 October 2026. The board approved the appointment at its meeting that day.
CWD Other Announcement
CWD Ltd has filed its quarterly shareholding pattern statement in accordance with SEBI regulatory requirements.
CWD Other Announcement
CWD Ltd filed its quarterly shareholding pattern as per Regulation 31 of SEBI LODR regulations. This is a routine regulatory compliance disclosure.
CWD Annual General Meeting
CWD Limited held its 10th Annual General Meeting on September 30, 2026. The company transacted all scheduled business including director re-appointments and financial statement adoption.
CWD Capital Structure Change
CWD Limited allotted 1,15,654 equity shares upon warrant conversion and 4,62,616 bonus shares. This allotment increases the paid-up capital of the company.
- Value
- ₹7.87 Cr
CWD Other Announcement
CWD Ltd filed its quarterly shareholding pattern as per Regulation 31(1)(c). No significant changes or corporate events were reported in this disclosure.
Other bonus issue announcements
All →Shreeji Global FMCG Bonus Issue
Shreeji Global FMCG board recommended a 1:1 bonus issue funded from securities premium, with no cash paid. Paid-up capital rises from Rs.22.76 Crore to Rs.49.92 Crore.
Concord Biotech Bonus Issue
Concord Biotech fixed 4 November 2026 as the record date for a 1:1 bonus issue, with deemed allotment on 5 November 2026. The bonus is subject to statutory and regulatory approvals.
Anlon Technology Solutions Bonus Issue
Anlon Technology Solutions fixed 02-Nov-2026 as the record date for its 2:5 bonus issue of equity shares. The bonus is free shares from reserves, with no cash paid.
Concord Biotech Bonus Issue
Concord Biotech's postal ballot approved a bonus issue and an authorised capital increase. No cash is paid and no ratio is stated.
Titan Biotech Bonus Issue
Titan Biotech allotted 1,03,29,625 bonus shares of Rs. 2 each in a 1:4 ratio. Paid-up capital rose to Rs. 10.33 Crore post-allotment.
Utssav CZ Gold Jewels Bonus Issue
Utssav CZ Gold Jewels' board recommended a 1:1 bonus issue from free reserves on 23 October 2026. Paid-up capital rises from Rs.25.00 Crore to Rs.50.00 Crore, subject to AGM/postal ballot on 25 November 2026.